American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Norfolk Southern
NSC
|
+$386M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
+$257M |
| 3 |
Texas Instruments
TXN
|
+$245M |
| 4 |
HEICO Corp
HEI
|
+$195M |
| 5 |
T. Rowe Price
TROW
|
+$192M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$406M |
| 2 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$308M |
| 3 |
Boeing
BA
|
+$273M |
| 4 |
Pfizer
PFE
|
+$272M |
| 5 |
Union Pacific
UNP
|
+$226M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.14% |
| 2 | Healthcare | 16.32% |
| 3 | Financials | 15.25% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Industrials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Western Alliance Bancorporation
WAL
$8.92B
| $1.88M | ﹤0.01% |
61,283
+33,381
| +120% | +$1.6M |
|
852
Ironwood Pharmaceuticals
IRWD
$674M
| $1.86M | ﹤0.01% |
184,262
+43,356
| +31% | +$510K |
|
853
Sensient Technologies
SXT
$5.53B
| $1.85M | ﹤0.01% |
+42,567
| New | +$2.35M |
|
854
Hecla Mining
HL
$11.9B
| $1.84M | ﹤0.01% |
1,012,457
+705,673
| +230% | +$1.95M |
|
|
WDR
855
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $1.83M | ﹤0.01% |
160,785
+85,949
| +115% | +$1.28M |
|
856
Cannae Holdings
CNNE
$675M
| $1.82M | ﹤0.01% |
+54,421
| New | +$2.02M |
|
|
MSGN
857
DELISTED
MSG Networks Inc.
MSGN
| $1.81M | ﹤0.01% |
+177,325
| New | +$2.53M |
|
|
AIMT
858
DELISTED
Aimmune Therapeutics
AIMT
| $1.79M | ﹤0.01% |
124,387
-87,507
| -41% | -$2.24M |
|
859
Iridium Communications
IRDM
$5.27B
| $1.78M | ﹤0.01% |
+79,899
| New | +$2.07M |
|
860
STAAR Surgical
STAA
$1.26B
| $1.78M | ﹤0.01% |
55,125
| – | – |
|
861
Infosys
INFY
$50.3B
| $1.77M | ﹤0.01% |
216,092
+89,064
| +70% | +$896K |
|
|
CSII
862
DELISTED
Cardiovascular Systems, Inc.
CSII
| $1.76M | ﹤0.01% |
50,067
+16,532
| +49% | +$697K |
|
863
First Commonwealth Financial
FCF
$2.19B
| $1.76M | ﹤0.01% |
192,534
+1,023
| +0.5% | +$12.7K |
|
864
Moelis & Co
MC
$5.21B
| $1.76M | ﹤0.01% |
62,648
+56,311
| +889% | +$1.85M |
|
865
Bank of N.T. Butterfield & Son
NTB
$2.51B
| $1.76M | ﹤0.01% |
103,108
+50,354
| +95% | +$1.48M |
|
866
SPS Commerce
SPSC
$2.86B
| $1.74M | ﹤0.01% |
37,302
| – | – |
|
|
AGN
867
DELISTED
Allergan plc
AGN
| $1.73M | ﹤0.01% |
9,751
-205,663
| -95% | -$38.7M |
|
|
EGOV
868
DELISTED
NIC Inc
EGOV
| $1.71M | ﹤0.01% |
74,438
+8,160
| +12% | +$167K |
|
|
NVO
869
Novo Nordisk
NVO
$205B
| $1.71M | ﹤0.01% |
56,698
+37,296
| +192% | +$1.11M |
|
870
National Beverage
FIZZ
$2.93B
| $1.7M | ﹤0.01% |
+79,918
| New | +$1.75M |
|
|
AMTD
871
DELISTED
TD Ameritrade Holding Corp
AMTD
| $1.69M | ﹤0.01% |
+48,669
| New | +$2.12M |
|
872
Cimpress
CMPR
$2.37B
| $1.68M | ﹤0.01% |
31,619
+324
| +1% | +$32.9K |
|
873
UFP Industries
UFPI
$5.03B
| $1.68M | ﹤0.01% |
45,166
-86,340
| -66% | -$3.97M |
|
874
Synaptics
SYNA
$4.2B
| $1.67M | ﹤0.01% |
28,787
-11,487
| -29% | -$779K |
|
875
Corcept Therapeutics
CORT
$11.9B
| $1.66M | ﹤0.01% |
139,933
+71,776
| +105% | +$888K |
|
Similar funds
American Century Companies's Q1 2020 Portfolio in Review
As of Q1 2020, American Century Companies held 1,788 positions worth $83.9B, down 20% from $105B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
American Century Companies's Q1 2020 filing shows 295 new, 795 increased, 493 reduced and 185 closed positions. Its largest new stake was IQVIA: 1,154,404 shares worth $125M. The largest sale was PepsiCo, an estimated $406M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- American Century Companies's largest Q1 2020 buy was IQVIA: 1,154,404 shares worth $125M.
- American Century Companies added most to Norfolk Southern in Q1 2020, an estimated $386M increase.
- American Century Companies's biggest Q1 2020 reduction was PepsiCo, cutting an estimated $406M.
- American Century Companies fully exited TotalEnergies in Q1 2020, selling an estimated $139M.
- American Century Companies's ten largest holdings make up 21% of its $83.9B portfolio in Q1 2020.
- American Century Companies opened 295 new positions and closed 185 in Q1 2020.
- American Century Companies's portfolio value fell 20% quarter-over-quarter to $83.9B.
Based on American Century Companies's 13F filing for Q1 2020, filed 14 May 2020.